Nathan Pennell

Nathan Pennell: EGFR mutation testing, treatment and survival in stage I–III NSCLC

Nathan Pennell, Professor and Vice Chair of Clinical Research at Cleveland Clinic, shared on X:            .

“Happy to see our paper out led by Bharathi Muthusamy.

EGFR mutation testing, treatment and survival in stage I–III non-small-cell lung cancer: CancerLinQ Discovery database retrospective analysis.”

Image

Proceed to the article.
Source: Nathan Pennell/X

Bharathi Muthusamy cancer CancerLinQ Discovery Cleveland Clinic EGFR mutation testing Nathan Pennell non small cell lung cancer NSCLC OncoDaily Oncology survival treatment